Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Mental health difficulties in children increased during the first national lockdown (between March and June 2020), but have decreased since.

Primary school children running into school

The latest report from the Co-SPACE study highlights that for participating primary school aged children:

  • Over the course of the first national lockdown (March - June 2020), behavioural and restless/attentional difficulties increased, while most children were not attending school.
  • Behavioural, emotional, and restless/attentional difficulties have generally decreased from July (i.e. when home schooling demands typically reduce), throughout the summer holidays, and as children returned to school in September.

Participating parents and carers reported that their children displayed increasing behaviour difficulties from March to June 2020, including temper tantrums, arguments and not doing what they were being asked to do by adults. They also became more fidgety and restless and had greater difficulty paying attention. However, parents and carers reported a decrease in these difficulties from July to October. Since then, children have also been reported to display fewer emotional difficulties, such as feeling unhappy, worried, being clingy and experiencing physical symptoms associated with worry.

The full story is available on the University of Oxford website

Similar stories

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.